Integer acquired by KKR: fairness opinion
Announced August 3, 2026 · Merger ·
DEFM14A filed September 14, 2026
Enterprise value
$5.7B
EV / LTM EBITDA
14.6x
EBITDA $392M · 21% margin
EV / LTM revenue
3.09x
revenue $1.8B
DCF discount rate
9.0%–10.0%
Deal terms
Consideration—
Price per share—
Premium—
Premium basis—
StructureMerger
Termination fee—
Reverse termination fee—
Go-shopNone
Outside date—
FilingDEFM14A · EDGAR index
3,000+ healthcare deal-level valuation multiples
The Valuation database includes financial details for more than 3,000 healthcare M&A transactions, private and public, with deal-level multiples, categorized by segment, type, and year.
Management projections
| Projection year | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | $2.0B | $2.2B | $2.4B | $2.5B | $2.7B | 8.4% |
| Revenue growth | 6.7% | 10.1% | 8.7% | 7.6% | 7.5% | |
| EBITDA | $433M | $497M | $560M | $623M | $689M | 12.3% |
| EBITDA growth | 10.6% | 14.8% | 12.7% | 11.3% | 10.6% | |
| EBITDA margin | 22% | 23% | 24% | 25% | 25% | |
| Implied EV / EBITDA | 13.2x | 11.5x | 10.2x | 9.1x | 8.3x |
Year-1 growth is against LTM at announcement ($1.8B revenue, $392M EBITDA); later years are year over year.
Other Medical Devices and Supplies fairness opinions
- Sanara MedTech / MiMedx Group 2026 · 20.6x EV/EBITDA
- Avanos Medical / American Industrial Partners 2026 · 14.7x EV/EBITDA
- Penumbra / Boston Scientific 2026 · 57.7x EV/EBITDA
- Varex Imaging / Teledyne Technologies 2026 · 9.4x EV/EBITDA
- Hologic / Blackstone / TPG 2025 · 14.1x EV/EBITDA
- ZimVie / ARCHIMED 2025 · 10.8x EV/EBITDA